Literature DB >> 16652304

In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.

Eugenne Elliott1, Adrian J Brink, Johan van Greune, Zia Els, Neil Woodford, Jane Turton, Marina Warner, David M Livermore.   

Abstract

Four sequential extended-spectrum beta -lactamase-producing isolates of Klebsiella pneumoniae were obtained from a patient after treatment with ertapenem and cultured. The first and fourth isolates were susceptible to ertapenem, whereas the second and third were resistant. All 4 isolates belonged to the same strain and produced a group 1 CTX-M enzyme; additionally, the resistant isolates had lost a porin.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16652304     DOI： 10.1086/503264

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  30 in total

1.  Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa.

Authors:  Adrian J Brink; Jennifer Coetzee; Cornelis G Clay; Sindi Sithole; Guy A Richards; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

3.  Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.

Authors:  Rajnikant Sharma; Saloni Patel; Cely Abboud; John Diep; Neang S Ly; Jason M Pogue; Keith S Kaye; Jian Li; Gauri G Rao
Journal:  Int J Antimicrob Agents       Date:  2016-12-23       Impact factor: 5.283

4.  New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.

Authors:  Ines Schneider; Anne Marie Queenan; Rumyana Markovska; Boyka Markova; Emma Keuleyan; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

5.  Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae.

Authors:  Christine Seah; Donald E Low; Samir N Patel; Roberto G Melano
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

6.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

Review 7.  Clinical management of infections caused by multidrug-resistant Enterobacteriaceae.

Authors:  Mercedes Delgado-Valverde; Jesús Sojo-Dorado; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  Ther Adv Infect Dis       Date:  2013-04

8.  Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.

Authors:  Azita Leavitt; Inna Chmelnitsky; Raul Colodner; Itzhak Ofek; Yehuda Carmeli; Shiri Navon-Venezia
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

9.  Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.

Authors:  G B Orsi; A Bencardino; A Vena; A Carattoli; C Venditti; M Falcone; A Giordano; M Venditti
Journal:  Infection       Date:  2012-10-16       Impact factor: 3.553

10.  Ertapenem resistance of Escherichia coli.

Authors:  Marie-Frédérique Lartigue; Laurent Poirel; Claire Poyart; Hélène Réglier-Poupet; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.